AxoGen, Inc. (AXGN) vs Celldex Therapeutics, Inc. (CLDX)
A side-by-side comparison of AxoGen, Inc. and Celldex Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AXGN
AxoGen, Inc.
$36.27HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
CLDX
Celldex Therapeutics, Inc.
$31.13HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — AXGN vs CLDX
growth of $100 · dividends reinvested · last 10yAXGN +326.8% (+15.6%/yr)CLDX -36.8% (-4.5%/yr)AXGN compounded faster over this window
Log scale — wide-divergence pair
AXGN CLDX
AXGN vs CLDX: by the numbers
- •CLDX is the larger company ($2.07B vs $1.95B market cap).
- •Both run net losses; AXGN's is the smaller (-13.36% vs -268385.71% net margin).
- •AXGN grew revenue faster over the past five years (13.99% vs -58.05% CAGR).
Metrics side by side
Valuation
| Metric | AXGN | CLDX |
|---|---|---|
| Forward P/E | 81.97 | N/A |
| P/S ratio | 7.76 | 18494.13 |
| P/B ratio | 7.61 | 2.90 |
| FCF yield | 0.13% | N/A |
Profitability
| Metric | AXGN | CLDX |
|---|---|---|
| Gross margin | 74.56% | 100.00% |
| Operating margin | -5.12% | -19160.00% |
| Net margin | -13.36% | -268385.71% |
| ROE | -13.09% | -42.07% |
| ROIC | -4.68% | -45.19% |
Growth (annualized)
| Metric | AXGN | CLDX |
|---|---|---|
| Revenue CAGR (5Y) | 13.99% | -58.05% |
| Total return CAGR (5Y) | 19.40% | -10.28% |
Frequently asked
- Which has grown faster, AXGN or CLDX?
- Over the past five years, AXGN grew revenue faster — AXGN at a 13.99% CAGR versus CLDX at -58.05%.
- How have AXGN and CLDX total returns compared?
- Over the past 10 years, AXGN delivered 15.98% and CLDX delivered -6.79% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AxoGen ROECelldex Therapeutics ROEAxoGen operating marginCelldex Therapeutics operating marginAxoGen revenue growthCelldex Therapeutics revenue growthAxoGen free cash flowCelldex Therapeutics free cash flow
AxoGen & Celldex Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.